2,779
Views
15
CrossRef citations to date
0
Altmetric
Research Papers

Ligand-based design and synthesis of N'-Benzylidene-3,4-dimethoxybenzohydrazide derivatives as potential antimicrobial agents; evaluation by in vitro, in vivo, and in silico approaches with SAR studies

, ORCID Icon, , , , , , , , , , , , , & ORCID Icon show all
Pages 1098-1119 | Received 20 Jan 2022, Accepted 03 Apr 2022, Published online: 18 Apr 2022

References

  • de Pauw BE. What are fungal infections? Mediterr J Hematol Infect Dis 2011;3:e2011001.
  • Tratrat C, Haroun M, Paparisva A, et al. Design, synthesis and biological evaluation of new substituted 5-benzylideno-2-adamantylthiazol [3, 2-b][1, 2, 4] triazol-6 (5H) ones. Pharmacophore models for antifungal activity. Arab J Chem 2018;11:573–90.
  • Mancabelli L, Milani C, Lugli GA, et al. Identification of universal gut microbial biomarkers of common human intestinal diseases by meta-analysis. FEMS Microbiol Ecol 2017;93:fix153.
  • Britannica "Bacterial disease". https://www.britannica.com/science/bacterial-disease.
  • El-Shershaby MH, El-Gamal KM, Bayoumi AH, et al. The antimicrobial potential and pharmacokinetic profiles of novel quinoline-based scaffolds: synthesis and in silico mechanistic studies as dual DNA gyrase and DHFR inhibitors. N J Chem 2021;45:13986–4004.
  • Lal K, Yadav P, Kumar A, et al. Design, synthesis, characterization, antimicrobial evaluation and molecular modeling studies of some dehydroacetic acid-chalcone-1,2,3-triazole hybrids. Bioorg Chem 2018;77:236–44.
  • El Malah T, Nour HF, Satti AA, et al. Design, synthesis, and antimicrobial activities of 1, 2, 3-triazole glycoside clickamers. Molecules 2020;25:790.
  • Woodford N, Ellington MJ. The emergence of antibiotic resistance by mutation. Clin Microbiol Infect 2007;13:5–18.
  • Lee PR, Lin C. The antibiotic paradox: how the misuse of antibiotics destroys their curative powers. Perspect Biol Med 2003;46:603–4.
  • Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf 2014;5:229–41.
  • Abo-Ashour MF, Eldehna WM, George RF, et al. Novel indole-thiazolidinone conjugates: design, synthesis and whole-cell phenotypic evaluation as a novel class of antimicrobial agents. Eur J Med Chem 2018;160:49–60.
  • Lee C-R, Lee JH, Park M, et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol 2017;7:55.
  • Singh H, Thangaraj P, Chakrabarti A. Acinetobacter baumannii: a brief account of mechanisms of multidrug resistance and current and future therapeutic management. J Clin Diagn Res 2013;7:2602–5.
  • Ciofu O, Tolker-Nielsen T. Tolerance and resistance of Pseudomonas aeruginosa biofilms to antimicrobial agents-how P. aeruginosa can escape antibiotics. Front Microbiol 2019;10:913.
  • Munikrishnappa CS, Suresh Kumar GV, Bhandare RR, et al. Multistep synthesis and screening of heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) as antimicrobial and anticancer agents. J Saudi Chem Soc 2022;26:101447.
  • Viegas-Junior C, Danuello A, da Silva Bolzani V, et al. Molecular hybridization: a useful tool in the design of new drug prototypes. Curr Med Chem 2007;14:1829–52.
  • Barreiro EJ, Fraga CA, Miranda AL, Rodrigues CR. Medicinal chemistry of n-acylhydrazones: novel lead-compounds of analgesic, antiinflammatory and antithrombotic drugs. Química Nova 2002;25:129–48.
  • Khalifa MM, Al-Karmalawy AA, Elkaeed EB, et al. Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies. J Enzyme Inhib Med Chem 2022;37:299–314.
  • El‐Helby AGA, Sakr H, Eissa IH, et al. Benzoxazole/benzothiazole‐derived VEGFR‐2 inhibitors: design, synthesis, molecular docking, and anticancer evaluations. Archiv Der Pharmazie 2019;352:1900178.
  • Donadio S, Maffioli S, Monciardini P, et al. Antibiotic discovery in the twenty-first century: current trends and future perspectives. J Antibiot 2010;63:423–30.
  • Al-Karmalawy AA, Khattab M. Molecular modelling of mebendazole polymorphs as a potential colchicine binding site inhibitor. N J Chem 2020;44:13990–6.
  • Kusakizako T, Miyauchi H, Ishitani R, Nureki O. Structural biology of the multidrug and toxic compound extrusion superfamily transporters. Biochim Biophys Acta Biomembr 2020;1862:183154.
  • Verma P, Tiwari M, Tiwari V. Efflux pumps in multidrug-resistant Acinetobacter baumannii: current status and challenges in the discovery of efflux pumps inhibitors. Microb Pathog 2021;152:104766.
  • Ahmad I, Nawaz N, Dermani FK, et al. Bacterial multidrug efflux proteins: a major mechanism of antimicrobial resistance. Curr Drug Targets 2018;19:1–13.
  • Radchenko M, Symersky J, Nie R, Lu M. Structural basis for the blockade of MATE multidrug efflux pumps. Nat Commun 2015;6:1–11.
  • Swarupa RG, Mohammed AA. Design, synthesis, antibacterial evaluation and molecular docking studies of some newer benzothiazole containing aryl and alkaryl hydrazides. Chem Biodivers 2021;18:1–15.
  • Wang L-H, Qiu X-Y, Liu S-J. Synthesis, characterization and crystal structures of Cobalt(II), Zinc(II) and Cadmium(II) complexes derived from 2-Hydroxy-N'-(pyridin-2-ylmethylene)benzohydrazide with antimicrobial activity. Acta Chimica Slovenica 2019;66:675–80.
  • Saini M, Kumar P, Kumar M, et al. Synthesis, in vitro antimicrobial, anticancer evaluation and QSAR studies of N′-(substituted)-4-(butan-2-lideneamino) benzohydrazides. Arabian J Chem 2014;7:448–60.
  • Krátký M, Konečná K, Brablíková M, et al. Iodinated 1,2-diacylhydrazines, benzohydrazide-hydrazones and their analogues as dual antimicrobial and cytotoxic agents. Bioorg Med Chem 2021;41:116209.
  • Pradeep K, Narasimhan B, Ramasamy K, et al. Synthesis, antimicrobial, anticancer evaluation and QSAR studies of 2/3-bromo-N0-(substituted benzylidene/3-phenylallylidene)-benzohydrazides. Arab J Chem 2014;10:S3740–S3748.
  • Takenouchi T, Munekata E. Amyloid β-peptide-induced inhibition of MTT reduction in PC12h and C1300 neuroblastoma cells: effect of nitroprusside. Peptides 1998;19:365–72.
  • Zebbiche Z, Tekin S, Küçükbay H, et al. Synthesis and anticancer properties of novel hydrazone derivatives incorporating pyridine and isatin moieties. Archiv Der Pharmazie 2021;354:2000377.
  • Young DH, Shaber SH, Avila-Adame C, et al. Synergistic fungicidal compositions including hydrazone derivatives and copper. Google Patents: 2012.
  • Sundaree S, Vaddula BR, Tantak MP, et al. Synthesis and anticancer activity study of indolyl hydrazide–hydrazones. Med Chem Res 2016;25:941–50.
  • Rector D, Conder G, Folz S. Preparation of antihelmintic acylhydrazones, method of use and compositions. PCT Int Appl 1987;57.
  • Wang Q-b, Sun L-y, Gong Z-d, Du Y. Veratric acid inhibits LPS-induced IL-6 and IL-8 production in human gingival fibroblasts. Inflammation 2016;39:237–42.
  • Inc., C. C. G., Molecular operating environment (MOE). Chemical Computing Group Inc 1010 Sherbooke St. West, Suite# 910, Montreal. 2016.
  • El Gizawy HA, Boshra SA, Mostafa A, et al. Pimenta dioica (L.) Merr. bioactive constituents exert anti-SARS-CoV-2 and anti-inflammatory activities: molecular docking and dynamics, in vitro, and in vivo studies. Molecules 2021;26:5844.
  • Shoala T, Al-Karmalawy AA, Germoush MO, et al. Nanobiotechnological approaches to enhance potato resistance against Potato Leafroll Virus (PLRV) using glycyrrhizic acid ammonium salt and salicylic acid nanoparticles. Horticulturae 2021;7:402.
  • Elebeedy D, Elkhatib WF, Kandeil A, et al. Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights. RSC Advances 2021;11:29267–86.
  • Zaki AA, Ashour A, Elhady SS, et al. Calendulaglycoside A showing potential activity against SARS-CoV-2 main protease: molecular docking, molecular dynamics, and SAR studies. J Tradit Complement Med 2022;12:16–34.
  • Eliaa SG, Al-Karmalawy AA, Saleh RM, Elshal MF. Empagliflozin and doxorubicin synergistically inhibit the survival of triple-negative breast cancer cells via interfering with the mTOR pathway and inhibition of calmodulin: in vitro and molecular docking studies. ACS Pharmacol Transl Sci 2020;3:1330–8.
  • Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. Int Sch Res Notices 2012;2012:1–10.
  • Scalbert A, Morand C, Manach C, Rémésy C. Absorption and metabolism of polyphenols in the gut and impact on health. Biomed Pharmacother 2002;56:276–82.
  • Thanou M, Verhoef J, Junginger H. Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev 2001;52:117–26.
  • Sullins AK, Abdel-Rahman SM. Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. Paediatr Drugs 2013;15:93–117.
  • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3–25.
  • Levy DD, Zeiger E, Escobar PA, et al. Recommended criteria for the evaluation of bacterial mutagenicity data (Ames test). Mutat Res Genet Toxicol Environ Mutagen 2019;848:403074.
  • Roy S, Mathew M. Fluid flow modulates electrical activity in cardiac hERG potassium channels. J Biol Chem 2018;293:4289–303.
  • Sanguinetti MC. HERG1 channel agonists and cardiac arrhythmia. Curr Opin Pharmacol 2014;15:22–7.
  • Xue W, Li X, Ma G, et al. N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: design, synthesis, biological evaluation and target identification. Eur J Med Chem 2020;188:112022.
  • Jia B, Ma Y-m, Liu B, et al. Synthesis, antimicrobial activity, structure-activity relationship, and molecular docking studies of indole diketopiperazine alkaloids. Front Chem 2019;7:837.
  • Tranmer M, Elliot M. Multiple linear regression. Cathie Marsh Centre Census Survey Res 2008;5:1–5.
  • Jorgensen JH, Hindler JF, Reller LB, Weinstein MP. New consensus guidelines from the clinical and laboratory standards institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. Clin Infect Dis 2007;44:280–6.
  • Tagg J, McGiven A. Assay system for bacteriocins. Appl Microbiol 1971;21:943.
  • Hombach M, Maurer FP, Pfiffner T, et al. Standardization of operator-dependent variables affecting precision and accuracy of the disk diffusion method for antibiotic susceptibility testing. J Clin Microbiol 2015;53:3864–69.
  • Rodriguez-Tudela J, Barchiesi F, Bille J, et al. Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts. Clin Microbiol Infect 2003;9:i–viii.
  • Fothergill AW, Antifungal susceptibility testing: clinical laboratory and standards institute (CLSI) methods. In Interactions of yeasts, moulds, and antifungal agents, Springer: 2012; pp 65–74.
  • Scudiero DA, Shoemaker RH, Paull KD, et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988;48:4827–33.
  • Paget G, Barnes J. Toxicity tests. Evaluation of drug activities: pharmacometrics 1964;1:135–65.
  • Diehl KH, Hull R, Morton D, et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 2001;21:15–23.
  • Kilkenny C, Browne W, Cuthill IC, et al. Animal research: reporting in vivo experiments: the ARRIVE guidelines. British J Pharmacol 2010;160:1577–9.
  • Council NR, Guide for the care and use of laboratory animals. 2010.
  • Simmons M, Brick JO, The laboratory mouse: selection and management. The laboratory mouse: selection and management. 1970.
  • Ding S-P, Li J-C, Jin C. A mouse model of severe acute pancreatitis induced with caerulein and lipopolysaccharide. World J Gastroenterol 2003;9:584.
  • Ochei JO, Kolhatkar AA, Medical laboratory science: theory and practice. New York: McGraw Hill Education: 2000.
  • Sims KL, Darcy TP. A leadership-management training curriculum for pathology residents. Am J Clin Pathol 1997;108:90–5.
  • Toora B, Rajagopal G, Measurement of creatinine by Jaffe's reaction-determination of concentration of sodium hydroxide required for maximum color development in standard, urine and protein free filtrate of serum. 2002.
  • Nicola N, Guidebook to cytokines and their receptors. Oxford: Oxford University Press: 1994.
  • Croft M, Duan W, Choi H, et al. TNF superfamily in inflammatory disease: translating basic insights. Trends Immunol 2012;33:144–152.
  • Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968;25:192–205.
  • Tietez F, Enzymic method for quantitative determination of nanogram amounts of total and oxidized. 1969.
  • Banchroft J, Stevens A, Turner D, Theory and practice of histological techniques. New York, London, San Francisco, Tokyo: Churchil Livingstone; 1996.
  • Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577–580.
  • Ahmed ZSO, Hussein S, Ghandour RA, et al. Evaluation of the effect of methotrexate on the hippocampus, cerebellum, liver, and kidneys of adult male albino rat: histopathological, immunohistochemical and biochemical studies. Acta Histochemica 2021;123:151682.
  • Bland M, An introduction to medical statistics. Oxford: Oxford University Press; 2015.
  • Weinberg SL, Abramowitz SK, Statistics using SPSS: an integrative approach. Cambridge: Cambridge University Press; 2008.
  • Zaki AA, Al‐Karmalawy AA, Khodir AE, et al. Isolation of cytotoxic active compounds from Reichardia tingitana with investigation of apoptosis mechanistic induction: in silico, in vitro, and SAR studies. South African J Botany 2022;144:115–123.
  • Samra RM, Soliman AF, Zaki AA, et al. Bioassay-guided isolation of a new cytotoxic ceramide from Cyperus rotundus L. South African Journal of Botany 2021;139:210–216.
  • Raslan MA, F. Taher R, Al-Karmalawy AA, et al. Cordyline fruticosa (L.) A. Chev. leaves: isolation, HPLC/MS profiling and evaluation of nephroprotective and hepatoprotective activities supported by molecular docking. N J Chem 2021;45:22216–22233.
  • Elmaaty AA, Darwish KM, Khattab M, et al. In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins. J Biomol Struct Dyn 2021;30:1–28.
  • Aziz MA, Shehab WS, Al-Karmalawy AA, et al. Design, synthesis, biological evaluation, 2D-QSAR modeling, and molecular docking studies of novel 1H-3-indolyl derivatives as significant antioxidants. Int J Mol Sci 2021;22:10396.
  • Diab RT, Abdel-Sami ZK, Abdel-Aal EH, et al. Design and synthesis of a new series of 3,5-disubstituted-1,2,4-oxadiazoles as potential colchicine binding site inhibitors: antiproliferative activity, molecular docking, and SAR studies. N J Chem 2021;45:21657–21669.,
  • Mahmoud DB, Bakr MM, Al-karmalawy AA, et al. Scrutinizing the feasibility of nonionic surfactants to form isotropic bicelles of curcumin: a potential antiviral candidate against COVID-19. AAPS PharmSciTech 2021;23:44.
  • Salem MA, Aborehab NM, Al-Karmalawy AA, et al. Potential valorization of edible nuts by-products: exploring the immune-modulatory and antioxidants effects of selected nut shells extracts in relation to their metabolic profiles. Antioxidants 2022;11:462.
  • Mahmoud A, Mostafa A, Al-Karmalawy AA, et al. Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies. Heliyon 2021;7:e07962.
  • Soltane R, Chrouda A, Mostafa A, et al. Strong inhibitory activity and action modes of synthetic maslinic acid derivative on highly pathogenic coronaviruses: COVID-19 drug candidate. Pathogens 2021;10:623.
  • Elmaaty AA, Alnajjar R, Hamed MI, et al. Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study. RSC Adv 2021;11:10027–10042.
  • Elmaaty AA, Darwish KM, Chrouda A, et al. In silico and in vitro studies for benzimidazole anthelmintics repurposing as VEGFR-2 antagonists: novel mebendazole-loaded mixed micelles with enhanced dissolution and anticancer activity. ACS Omega 2022;7:875–899.
  • El-Masry R, Al-Karmalawy AA, Alnajjar RA, et al. Newly synthesized series of oxoindole-oxadiazole conjugates as potential anti-SARS-CoV-2 agents: in silico and in vitro studies. N J Chem 2022;46:5078–5090.
  • Al-Karmalawy AA, Alnajjar R, Dahab M, et al. Molecular docking and dynamics simulations reveal the potential of anti-HCV drugs to inhibit COVID-19 main protease. Pharm Sci 2021;27(Suppl 1): S109–S121 .
  • Al-Karmalawy AA, Dahab MA, Metwaly AM, et al. Molecular docking and dynamics simulation revealed the potential inhibitory activity of ACEIs against SARS-CoV-2 targeting the hACE2 receptor. Front Chem 2021;9:661230.
  • El-Demerdash A, Al-Karmalawy AA, Abdel-Aziz TM, et al. Investigating the structure–activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors. RSC Advances 2021;11:31339–31363.
  • Abdallah AE, Alesawy MS, Eissa SI, et al. Design and synthesis of new 4-(2-nitrophenoxy)benzamide derivatives as potential antiviral agents: molecular modeling and in vitro antiviral screening. N J Chem 2021;45:16557–16571.
  • Elebeedy D, Badawy I, Elmaaty AA, et al. In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus. Comp Biol Med 2022;141:105149.
  • Taher RF, Al‐Karmalawy AA, Abd El Maksoud AI, et al. Two new flavonoids and anticancer activity of Hymenosporum flavum: in vitro and molecular docking studies. J Herbmed Pharmacol 2021;10:443–458.
  • Khattab M, Al‐Karmalawy AA. Revisiting activity of some nocodazole analogues as a potential anticancer drugs using molecular docking and DFT calculations. Front Chem 2021;9:92.
  • Al-Karmalawy AA, Farid MM, Mostafa A, et al. Naturally available flavonoid aglycones as potential antiviral drug candidates against SARS-CoV-2. Molecules 2021;26:6559.
  • Hazem RM, Antar SA, Nafea YK, et al. Pirfenidone and vitamin D mitigate renal fibrosis induced by doxorubicin in mice with Ehrlich solid tumor. Life Sciences 2022;288:120185.
  • Ghanem A, Al-Karmalawy AA, Abd El Maksoud AI, et al. Rumex Vesicarius L. extract improves the efficacy of doxorubicin in triple-negative breast cancer through inhibiting Bcl2, mTOR, JNK1 and augmenting p21 expression. Inform Med Unlocked 2022;29:100869.
  • Mahmoud DB, Ismail WM, Moatasim Y, et al. Delineating a potent antiviral activity of Cuphea ignea extract loaded nano-formulation against SARS-CoV-2: In silico and in vitro studies. J Drug Delivery Sci Technol 2021;66:102845.
  • Khattab M, Al-Karmalawy AA. Computational repurposing of benzimidazole anthelmintic drugs as potential colchicine binding site inhibitors. Future Med Chem 2021;13:null–1638.
  • Hamed MIA, Darwish KM, Soltane R, et al. β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, in silico, in vitro, and SAR studies for lead optimization. RSC Adv 2021;11:35536–8.
  • Gaber AA, El‐Morsy AM, Sherbiny FF, et al. Pharmacophore‐linked pyrazolo [3, 4‐d] pyrimidines as EGFR‐TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies. Archiv Der Pharmazie 2021;e2100258.DOI:10.1002/ardp.202100258
  • Al-Karmalawy A, Ma C, Taghour MS, et al. Design and synthesis of new quinoxaline derivatives as potential histone deacetylase inhibitors targeting hepatocellular carcinoma: in silico, in vitro, and SAR studies. Front Chem 2021;9:648.
  • El-Shershaby MH, Ghiaty A, Bayoumi AH, et al. From triazolophthalazines to triazoloquinazolines: a bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity. Bioorg Med Chem 2021;42:116266.
  • Alesawy MS, Al‐Karmalawy AA, Elkaeed EB, et al. J. A. d. P., Design and discovery of new 1, 2, 4‐triazolo [4, 3‐c] quinazolines as potential DNA intercalators and topoisomerase II inhibitors. Archiv Der Pharmazie 2021;354:e2000237.
  • Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7:42717–13.
  • Pires DE, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 2015;58:4066–72.